| Identification | Back Directory | [Name]
GP (33-41) | [CAS]
161928-86-5 | [Synonyms]
GP33 (1-9)
GP (33-41)
LCMV PEPTIDE
H2N-KAVYNFATM-OH
LYS-ALA-VAL-TYR-ASN-PHE-ALA-THR-MET
Lys-Ala-Val-Tyr-Asn-Phe-Ala-Thr-Cys
LYMPHOCYTIC CHORIOMENINGITIS VIRUS PEPTIDE | [Molecular Formula]
C48H73N11O13S | [MDL Number]
MFCD02181018 | [MOL File]
161928-86-5.mol | [Molecular Weight]
1044.22 |
| Chemical Properties | Back Directory | [Boiling point ]
1490.5±65.0 °C(Predicted) | [density ]
1.310±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in DMSO | [pka]
2.94±0.10(Predicted) | [Sequence]
Lys-Ala-Val-Tyr-Asn-Phe-Ala-Thr-Cys |
| Hazard Information | Back Directory | [Uses]
GP(33-41), a 9-aa-long peptide, is the optimal sequence of the GP1 epitope of lymphocytic choriomeningitis virus, and can upregulate H-2Db molecules at the RMA-S (Db Kb) cell surface with a SC50 of 344 nM[1]. | [References]
[1] Gairin JE, et al. Optimal lymphocytic choriomeningitis virus sequences restricted by H-2Db major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes. J Virol. 1995 Apr;69(4):2297-305. DOI:10.1128/JVI.69.4.2297-2305.1995
[2] Boulter JM, et al. Potent T cell agonism mediated by a very rapid TCR/pMHC interaction. Eur J Immunol. 2007 Mar;37(3):798-806. DOI:10.1002/eji.200636743 |
|
| Company Name: |
Ontores Biotech
|
| Tel: |
0571-88760729 18072970094 |
| Website: |
www.ontoresinc.cn |
|